Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2000-08-17 · DEPARTMENT OF JUSTICE · Notices

Notices. DEPARTMENT OF JUSTICE

328 words·~1 min read·/register/2000/08/17/00-20893

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4410-11-M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFR-134a (IPACT-I) Notice is hereby given that, on March 15, 2000, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 *et seq.* (“the Act”), International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFR-134a (IPACT-I) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership status.
The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Astra AB, a party to IPACT-I, changed its name to AstraZeneca AB, Sodertalje, SWEDEN; and Rhone-Poulenc Rorer Pharmaceuticals, Inc., a party to IPACT-I, changed its name to Aventis Pharma AG, Frankfurt am Main, GERMANY as a result of a corporate merger involving its holding company. The membership interest of Fisons plc in IPACT-I also has been transferred to Aventis Pharma AG as a result of the merger.
No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA-134a (IPACT-I) intends to file additional written notification disclosing all changes in membership. On August 7, 1990, International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA-134a (IPACT-I) filed its original notification pursuant to Section 6(a) of the Act.
The Department of Justice published a notice in the **Federal Register** pursuant to Section 6(b) of the Act on September 6, 1990 (55 FR 36710). The last notification was filed with the Department on December 3, 1997. A notice was published in the **Federal Register** pursuant to Section 6(b) of the Act on February 19, 1998 (63 FR 8477). Constance K. Robinson, Director of Operations, Antitrust Division. [FR Doc. 00-20893 Filed 8-16-00; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.